General Information of the Compound
| Compound ID |
CP0343816
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(8S,9R,10R,11S,13S,14S,17S)-17-(2-cyclopropylethynyl)-11-[4-(dimethylamino)phenyl]-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C32H41NO2
|
||||||||||||||||||
| Molecular Weight |
471.685
|
||||||||||||||||||
| Canonical SMILES |
CN(C)c1ccc(cc1)[C@H]1C[C@@]2(C)[C@@H](CC[C@@]2(O)C#CC2CC2)[C@@H]2CCC3=CC(=O)CC[C@]3(C)[C@@H]12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H41NO2/c1-30-16-14-25(34)19-23(30)9-12-26-28-15-18-32(35,17-13-21-5-6-21)31(28,2)20-27(29(26)30)22-7-10-24(11-8-22)33(3)4/h7-8,10-11,19,21,26-29,35H,5-6,9,12,14-16,18,20H2,1-4H3/t26-,27+,28-,29+,30-,31-,32-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
CMXFWOYVQQMVBK-XVFXGUTESA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00894, Androgen receptor
Protein ID: PT00967, Glucocorticoid receptor
Protein ID: PT01172, Progesterone receptor